HORN HOWARD (Chief Financial Officer) sold 5.5% of their position (4.68K shares) of ULTRAGENYX PHARMACEUTICAL INC. on the open market
Open‑market sale worth $98.2K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 4/2/2026ACC: 0001193125-26-140702
Officer· Chief Financial Officer
Since Mar 2026
-4.68K
Net shares
Net seller
$98.2K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
4.68K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−4.68K
Price / share
$20.97
Trade value
$98.20K
% of position
5.5%
4/1/2026
85.03K→80.35K
Total
Net shares
−4.68K
Net value
-$98.20K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/1/2026 | S · Sale | −4.68K | $20.97 | $98.20K | 5.5% | 85.03K | 80.35K |
| Total | −4.68K | -$98.20K | ||||||
Derivative Transactions0
No derivative transactions reported